Amphastar Pharmaceuticals... (AMPH)
28.48
0.11 (0.39%)
At close: Mar 27, 2025, 3:59 PM
28.20
-1.00%
Pre-market: Mar 28, 2025, 07:26 AM EDT
Amphastar Pharmaceuticals Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Revenue | 712.81M | 644.39M | 498.99M | 437.77M | 349.85M | 322.36M | 294.67M | 240.18M | 255.16M | 251.52M | 210.46M | 229.68M | 204.32M | 118.36M |
| Cost of Revenue | 338.96M | 293.27M | 250.13M | 238.03M | 206.51M | 190.43M | 187.68M | 149.38M | 150.98M | 174.17M | 159.21M | 142.72M | 114.02M | 90.25M |
| Gross Profit | 373.86M | 351.12M | 248.86M | 199.74M | 143.34M | 131.92M | 106.98M | 90.8M | 104.19M | 77.35M | 51.26M | 86.96M | 90.3M | 28.1M |
| Operating Income | 205.42M | 196.99M | 78.76M | 43.13M | -14.23M | -39K | -8.62M | -895K | 15.69M | -6.9M | -17.98M | 17.49M | 25.4M | -33.55M |
| Interest Income | 10.61M | 5.46M | 1.32M | 601K | 642K | 997K | 456K | 425K | 270K | 315K | 243K | 187K | 242K | 401K |
| Pretax Income | 189.76M | 171.36M | 116.04M | 84.14M | 4.64M | 60.23M | -9.93M | 1.62M | 14.95M | -10.36M | -18.15M | 17.23M | 25.88M | -31.89M |
| Net Income | 159.52M | 137.54M | 91.39M | 62.12M | 1.1M | 48.94M | -5.74M | 4.51M | 10.53M | -2.79M | -10.7M | 11.86M | 18.09M | 7.75M |
| Selling & General & Admin | 94.52M | 80.39M | 66.59M | 68.92M | 65.16M | 63.11M | 58.04M | 50.92M | 47.3M | 46.97M | 40.37M | 36.32M | 31.65M | 30.53M |
| Research & Development | 73.91M | 73.74M | 74.77M | 60.93M | 67.23M | 68.85M | 57.56M | 43.41M | 41.2M | 37.06M | 28.43M | 33.02M | 31.16M | 31.05M |
| Other Expenses | n/a | n/a | 8.54M | 14.25M | -6.32M | 60.27M | -1.3M | 2.52M | -746K | -2.79M | -165K | 508K | 1.02M | 1.84M |
| Operating Expenses | 168.44M | 154.13M | 141.36M | 129.85M | 132.39M | 131.96M | 115.61M | 94.33M | 88.5M | 84.04M | 68.8M | 69.34M | 62.81M | 61.58M |
| Interest Expense | 30.34M | 27.16M | 1.85M | 885K | 374K | 119K | 243K | 826K | 1.02M | 987K | 609K | 958K | 784K | 584K |
| Selling & Marketing Expenses | 37.8M | 28.85M | 21.53M | 17.49M | 14.78M | 12.83M | 8.16M | 6.46M | 5.47M | 5.47M | 5.56M | 5.35M | 4.43M | 4.1M |
| Cost & Expenses | 507.39M | 447.41M | 391.49M | 367.88M | 338.89M | 322.4M | 303.29M | 243.71M | 239.47M | 258.21M | 228M | 212.06M | 176.83M | 151.83M |
| Income Tax | 29.67M | 31.83M | 23.48M | 20.63M | 3.54M | 13.72M | -3.27M | -2.88M | 4.41M | -7.58M | -7.45M | 5.37M | 7.78M | -39.64M |
| Shares Outstanding (Basic) | 48.43M | 48.27M | 48.55M | 47.78M | 47.04M | 46.98M | 46.4M | 46.11M | 45.38M | 44.96M | 41.96M | 8M | 8M | 8M |
| Shares Outstanding (Diluted) | 52.06M | 53M | 52.43M | 49.78M | 49.12M | 49.91M | 46.4M | 48.37M | 47.5M | 44.96M | 41.96M | 8M | 8M | 8M |
| EPS (Basic) | 3.29 | 2.85 | 1.88 | 1.30 | 0.02 | 1.04 | -0.12 | 0.10 | 0.23 | -0.06 | -0.25 | 1.48 | 2.26 | 0.97 |
| EPS (Diluted) | 3.06 | 2.60 | 1.74 | 1.25 | 0.02 | 0.98 | -0.12 | 0.09 | 0.22 | -0.06 | -0.25 | 1.48 | 2.26 | 0.97 |
| EBITDA | 277.31M | 240.29M | 107.5M | 111.78M | 30.19M | 81.47M | 6.83M | 11.9M | 30.53M | 3.88M | -3.09M | 30.69M | 38.16M | -20.15M |
| Depreciation & Amortization | 57.2M | 41.78M | 28.74M | 26.75M | 25.18M | 21.12M | 16.52M | 15.81M | 14.56M | 13.25M | 14.45M | 13.08M | 11.5M | 11.15M |